Fetal Heart Interventricular Septum in Fetuses of Diabetic Mothers
- Conditions
- PregnancyDiabetes Mellitus
- Registration Number
- NCT01845324
- Lead Sponsor
- Hillel Yaffe Medical Center
- Brief Summary
The investigators asume that the measurement of the fetal heart interventricular septum can serve as a good tool to predict glucose control in pregnant patients with diabetes mellitus. The investigators will measure the septum width in patients with Diabetes and will correlate to standard measurements of the glucuse levels.
- Detailed Description
In this study the investigators will follow patients with Diabetes Mellitus - mainly gestational. the investigators will measure the width of the interventricular septum and correlate with conventional measures of blood glucose measurements in this population.
The investigators will try to assess whether measurement of the septum can be an earlier and better predictor of glucose control in this population.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 300
- All consequtive pregnant women
- with Diabetes Mellitus - Gestational and non Gestational
.No willing to participate.
- Suspected Heart anomaly
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method width of fetal interventricula heart septum 2 years The investigator will assess the width of the fetal interventricular septum in patients with diabetes.
- Secondary Outcome Measures
Name Time Method glucose control in patients with normal and abnormal interventricular septal width 2 years The investigators will try to show that small interventricular septal width glucose correlates with good glucose control
Trial Locations
- Locations (1)
Hillel Yaffe Medical Center
🇮🇱Hadera, Israel